September 2021

FDA Takes Steps Aimed at Improving Quality, Safety and Efficacy of Sunscreens

Sep 28, 2021 | National

The U.S. Food and Drug Administration today took steps aimed at improving the quality, safety, and efficacy of sunscreens as part of its implementation of new authorities for certain over-the-counter (OTC) drugs. In the short term, these new authorities essentially...

Amgen Releases 8th Edition of Biosimilar Trends Report

Sep 28, 2021 | Local

Report Finds That Competition Created by Biosimilars Delivered $9.8 Billion in Savings Over the Past Five Years to the U.S. Healthcare System, Generating Savings for Patients, Payers and EmployersWith Both a Strong Innovator Portfolio and a Deep Investment in...

Initiative to expand Ph.D. student diversity in STEM graduate programs has lasting positive effects

Sep 28, 2021 | Uncategorized

https://www.brown.edu/news/2021-07-08/imsd A study that looked at 10-year outcomes of the Initiative to Maximize Student Development showed that it increased diversity within academic programs and prepared underrepresented students for successful careers in STEM. In...

Bolden Therapeutics Receives $500,000 Small Business Grant from the National Institute on Aging

Sep 28, 2021 | Local

PROVIDENCE, RI & CAMBRIDGE, MA. Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for potential treatment of CNS diseases such as Alzheimer’s disease, today announced receiving a $500,000 Phase I...

FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations

Sep 23, 2021 | National

https://www.fda.gov/news-events/press-announcements/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations?utm_medium=email&utm_source=govdelivery Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA)...